Kurtuluş Şahin

1.5k total citations · 1 hit paper
32 papers, 1.1k citations indexed

About

Kurtuluş Şahin is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Kurtuluş Şahin has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 11 papers in Internal Medicine and 7 papers in Surgery. Recurrent topics in Kurtuluş Şahin's work include Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Mesenchymal stem cell research (7 papers). Kurtuluş Şahin is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Mesenchymal stem cell research (7 papers). Kurtuluş Şahin collaborates with scholars based in Germany, United States and United Kingdom. Kurtuluş Şahin's co-authors include Luise Tittl, Franziska Michalski, Jan Beyer‐Westendorf, Sebastian Werth, Sven Pannach, Norbert Weiss, Franziska Ebertz, Christina Köhler, Vera Gelbricht and Ulrike Hänsel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurosurgery.

In The Last Decade

Kurtuluş Şahin

31 papers receiving 1.1k citations

Hit Papers

Rates, management, and outcome of rivaroxaban bleeding in... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
    2014 311 citations Jan Beyer‐Westendorf, Sven Pannach et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurtuluş Şahin Germany 15 807 580 156 102 101 32 1.1k
Karin Strandberg Sweden 19 726 0.9× 615 1.1× 232 1.5× 126 1.2× 69 0.7× 72 1.4k
Krystyna Zawilska Poland 14 412 0.5× 462 0.8× 229 1.5× 87 0.9× 22 0.2× 90 1.2k
Beau M. Hawkins United States 13 235 0.3× 128 0.2× 224 1.4× 61 0.6× 45 0.4× 42 705
Charalambos Vlachopoulos Greece 8 238 0.3× 249 0.4× 321 2.1× 50 0.5× 22 0.2× 10 637
Fernando Ferrando Spain 17 223 0.3× 351 0.6× 73 0.5× 40 0.4× 25 0.2× 35 737
J H Chesebro United States 11 812 1.0× 237 0.4× 562 3.6× 68 0.7× 22 0.2× 19 1.2k
Wook-Sung Chung South Korea 15 756 0.9× 116 0.2× 597 3.8× 116 1.1× 18 0.2× 62 1.2k
Levine Mn Canada 7 425 0.5× 534 0.9× 370 2.4× 56 0.5× 14 0.1× 8 838
Paula F. Ypma Netherlands 15 162 0.2× 121 0.2× 63 0.4× 92 0.9× 30 0.3× 57 770
Marc Cairols Spain 17 281 0.3× 198 0.3× 379 2.4× 19 0.2× 59 0.6× 37 760

Countries citing papers authored by Kurtuluş Şahin

Since Specialization
Citations

This map shows the geographic impact of Kurtuluş Şahin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurtuluş Şahin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurtuluş Şahin more than expected).

Fields of papers citing papers by Kurtuluş Şahin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurtuluş Şahin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurtuluş Şahin. The network helps show where Kurtuluş Şahin may publish in the future.

Co-authorship network of co-authors of Kurtuluş Şahin

This figure shows the co-authorship network connecting the top 25 collaborators of Kurtuluş Şahin. A scholar is included among the top collaborators of Kurtuluş Şahin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurtuluş Şahin. Kurtuluş Şahin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Müller, Stephanie, Luise Tittl, Lara N. Roberts, et al.. (2022). Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry. Research and Practice in Thrombosis and Haemostasis. 6(7). e12829–e12829. 2 indexed citations
3.
Mantovani, LG, Sylvia Haas, Reinhold Kreutz, et al.. (2018). Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis. European Journal of Internal Medicine. 61. 29–33. 3 indexed citations
4.
Marten, Sandra, et al.. (2018). Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry. International Journal of Cardiology. 257. 276–282. 21 indexed citations
5.
Beyer‐Westendorf, Jan, Sebastian Schellong, H. Gerlach, et al.. (2017). Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. The Lancet Haematology. 4(3). e105–e113. 79 indexed citations
6.
Hecker, Judith S., Sandra Marten, Franziska Michalski, et al.. (2016). Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Thrombosis and Haemostasis. 115(5). 939–949. 115 indexed citations
7.
Gebel, Martin, et al.. (2015). Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Thrombosis and Haemostasis. 114(12). 1136–1143. 10 indexed citations
8.
Ebertz, Franziska, Vera Gelbricht, Franziska Michalski, et al.. (2015). Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Thrombosis and Haemostasis. 113(6). 1247–1257. 115 indexed citations
9.
Sagir, Abdurrahman, Kurtuluş Şahin, Dirk Graf, et al.. (2015). Transient Elastography for the Detection of Liver Damage in Patients with HIV. Infectious Diseases and Therapy. 4(3). 355–364. 6 indexed citations
10.
Förster, K., Thomas Schreier, Franziska Michalski, et al.. (2015). Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry. EP Europace. 17(4). 530–538. 119 indexed citations
11.
Hohnloser, Stefan H., Riccardo Cappato, Michael D. Ezekowitz, et al.. (2015). Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: apost hocanalysis of the X-VeRT trial. EP Europace. 18(2). 184–190. 26 indexed citations
12.
Bozdağ-Turan, İlkay, İbrahim Akın, Stephan Kische, et al.. (2012). Intra coronary freshly isolated bone marrow cells transplantation improve cardiac function in patients with ischemic heart disease. BMC Research Notes. 5(1). 195–195. 3 indexed citations
13.
Bozdağ-Turan, İlkay, Çetin Turan, İbrahim Akın, et al.. (2011). Relation between the frequency of CD34+ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes. Cardiovascular Diabetology. 10(1). 107–107. 14 indexed citations
14.
Turan, Ramazan Gökmen, Çetin Turan, Jasmin Ortak, et al.. (2011). Enhanced mobilization of the bone marrow–derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. Journal of Cellular and Molecular Medicine. 16(4). 852–864. 22 indexed citations
15.
Mösges, Ralph, Christian Baues, Timo Schröder, & Kurtuluş Şahin. (2011). Acute bacterial otitis externa: efficacy and safety of topical treatment with an antibiotic ear drop formulation in comparison to glycerol treatment. Current Medical Research and Opinion. 27(4). 871–878. 9 indexed citations
16.
Ortak, Jasmin, Stephan Kische, İbrahim Akın, et al.. (2010). Improved Functional Activity of Bone Marrow Derived Circulating Progenitor Cells After Intra Coronary Freshly Isolated Bone Marrow Cells Transplantation in Patients with Ischemic Heart Disease. Stem Cell Reviews and Reports. 7(3). 646–656. 24 indexed citations
17.
Turan, Ramazan Gökmen, İlkay Bozdağ-Turan, Jasmin Ortak, et al.. (2010). Improved Mobilization of the CD34 + and CD133 + Bone Marrow-Derived Circulating Progenitor Cells by Freshly Isolated Intracoronary Bone Marrow Cell Transplantation in Patients with Ischemic Heart Disease. Stem Cells and Development. 20(9). 1491–1501. 20 indexed citations
18.
Löhr, Mario, Marek Molčányi, Ralf-Ingo Ernestus, et al.. (2008). DEGENERATION OF CHOLINERGIC RAT BASAL FOREBRAIN NEURONS AFTER EXPERIMENTAL SUBARACHNOID HEMORRHAGE. Neurosurgery. 63(2). 336–345. 9 indexed citations
19.
Berthold, Frank, Kurtuluş Şahin, Barbara Hero, et al.. (1997). The current contribution of molecular factors to risk estimation in neuroblastoma patients. European Journal of Cancer. 33(12). 2092–2097. 41 indexed citations
20.
Christiansen, Holger, Kurtuluş Şahin, Frank Berthold, et al.. (1995). Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in Neuroblastoma. European Journal of Cancer. 31(4). 541–544. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Strandberg Breakdown of academic impact, for papers by Krystyna Zawilska Breakdown of academic impact, for papers by Beau M. Hawkins Breakdown of academic impact, for papers by Charalambos Vlachopoulos Breakdown of academic impact, for papers by Fernando Ferrando Breakdown of academic impact, for papers by J H Chesebro Breakdown of academic impact, for papers by Wook-Sung Chung Breakdown of academic impact, for papers by Levine Mn Breakdown of academic impact, for papers by Paula F. Ypma Breakdown of academic impact, for papers by Marc Cairols
Rankless by CCL
2026